Skip to content
2000
Volume 18, Issue 2
  • ISSN: 1574-8855
  • E-ISSN: 2212-3903

Abstract

Silymarin, is a phytoactive constituent isolated from the fruits and seeds of Silybum marianum L Gaetn.), also called milk thistle belonging to the family of Asteracease. The phytoactive has been used to treat several physiological disorders. The objective of this manuscript was to review the therapeutic prospective of silymarin due to its ability to treat several physiological disorders. The databases such as Pubmed, Elsevier, and Google Scholar were reviewed for the investigations or reviews published related to the title. The discussion is focused on the immunomodulatory, chemopreventive, and anti-inflammatory mechanisms of silymarin in various metabolic and dermatological disorders. In addition, the review discusses the different therapeutic potentials of silymarin such as the management of the liver disorder, skin carcinogenesis, cardiovascular disorders, diabetes mellitus, neurodegenerative disorders, and several dermatological disorders such as melasma, anti-aging, acne, rosacea, atopic dermatitis, and psoriasis. Silymarin is safe even with a dose higher than the therapeutic dose. Silymarin had good potential for the safe and effective treatment of numerous metabolic and dermatological disorders.

Loading

Article metrics loading...

/content/journals/cdth/10.2174/1574885518666221227100052
2023-04-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/cdth/10.2174/1574885518666221227100052
Loading

  • Article Type:
    Review Article
Keyword(s): atopic dermatitis; cardiomyopathy; dermatology; liver; silybinin; Silymarin; skin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test